Trial
NCT05727657
Satralizumab in Aneurysmal Subarachnoid Hemorrhage
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Florida
Collaborators
Genentech, Inc.
Condition
Aneurysmal Subarachnoid Hemorrhage
Intervention
Satralizumab
Why stopped
Lost support from the drug manufacturer
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-04